Of these subunits, we found that the mRNA level of AMPK-β1 was dominantly expressed and tightly correlated with AMPK activity when compared with AMPK-β2 during the progression of ovarian cancer [47] and other human cancers [48]. This evidence concerns the gene PRKAA2 and cancer.